The Gross Margin of Igene Biotechnology Inc (IGNE) is 25.66%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2009-12-31 | 25.66% |
2008-12-31 | 16.34% |
2007-12-31 | 26.45% |
2006-12-31 | 4.35% |
2005-12-31 | 9.17% |
2004-12-31 | 15.79% |
2003-12-31 | -12.86% |